Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT01430416 |
| Title | Safety and Efficacy of AEB071 in Metastatic Uveal Melanoma Patients |
| Recruitment | Completed |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | Novartis Pharmaceuticals |
| Indications | |
| Therapies | |
| Age Groups: | adult |
| Covered Countries | USA | NLD | GBR | FRA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Dana Farber Cancer Institute DFCI - Brookline | Boston | Massachusetts | 02215 | United States | Details | |
| Memorial Sloan Kettering MSKCC 4 | New York | New York | 10017 | United States | Details | |
| Novartis Investigative Site | Paris | 75231 | France | Details | ||
| Novartis Investigative Site | Leiden | 2300 RC | Netherlands | Details | ||
| Novartis Investigative Site | London | SW3 6JJ | United Kingdom | Details |